ARCHIVES

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

HHS, NIH Prepare for Government Shutdown

September 20, 2013

New Grant Program in Physical Activity

March 28, 2003

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007